menu
    • menu

    Company profile for Jnana Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Jnana, we are pioneering the development of small molecule drugs that target the SLC (solute carrier) family of metabolite transporters, which are key regulators of cellular metabolism. By building the first drug discovery platform targeting SLC transporters, Jnana is opening a broad, innovative approach for modulating cellular metabolism to treat a range of diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Jnana TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    6 Tide Street Boston, MA 02210
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.jnanatx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/jnana-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/jnanatx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Jnana Presents JNT-517 Data, Plans 2025 Pivotal Study
    Jnana Presents JNT-517 Data, Plans 2025 Pivotal Study

    04 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/04/2940409/0/en/Jnana-Therapeutics-Presents-New-Positive-Data-from-Phase-1-2-Study-of-JNT-517-in-Individuals-with-Phenylketonuria-Results-Support-Planned-Pivotal-Study-in-Early-2025.html

    GLOBENEWSWIRE
    04 Sep 2024
    Share Share
    Japan's Otsuka Pharma to pay up to $1.1 bln to acquire Jnana Therapeutics
    Japan's Otsuka Pharma to pay up to $1.1 bln to acquire Jnana Therapeutics

    01 Aug 2024

    // PRESS RELEASE

    https://www.otsuka.co.jp/en/company/newsreleases/2024/20240801_1.html

    PRESS RELEASE
    01 Aug 2024
    Share Share
    Nkarta Adds Experienced Leader in Autoimmune R&D
    Nkarta Adds Experienced Leader in Autoimmune R&D

    13 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/13/2898623/0/en/Nkarta-Adds-Experienced-Leader-in-Autoimmune-R-D-George-Vratsanos-M-D-FACR-to-Board-of-Directors.html

    GLOBENEWSWIRE
    13 Jun 2024
    Share Share
    Jnana At RBC Healthcare Conference
    Jnana At RBC Healthcare Conference

    08 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/08/2877784/0/en/Jnana-Therapeutics-to-Present-at-the-RBC-Capital-Markets-Global-Healthcare-Conference.html

    GLOBENEWSWIRE
    08 May 2024
    Share Share
    Jnana Therapeutics to Present Preclinical Data on its PKU Program
    Jnana Therapeutics to Present Preclinical Data on its PKU Program

    16 Mar 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230316005220/en

    BUSINESSWIRE
    16 Mar 2023
    Share Share
    Jnana Therapeutics to Participate in Upcoming Investor Conferences
    Jnana Therapeutics to Participate in Upcoming Investor Conferences

    01 Mar 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230301005135/en

    BUSINESSWIRE
    01 Mar 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search